EGFR-activating mutations correlate with a Fanconi anemia-like cellular phenotype that includes PARP inhibitor sensitivity.
about
Enhancing tumor-targeting monoclonal antibodies therapy by PARP inhibitorsPreclinical assessment of carboplatin treatment efficacy in lung cancer by 18F-ICMT-11-positron emission tomographyStructural insights into 5' flap DNA unwinding and incision by the human FAN1 dimer.DNA Damage Response Assessments in Human Tumor Samples Provide Functional Biomarkers of Radiosensitivity.Disruption of SLX4-MUS81 Function Increases the Relative Biological Effectiveness of Proton RadiationMinocycline Improves the Efficacy of EGFR Inhibitor Therapy: A Hypothesis.Gene expression and mutation-guided synthetic lethality eradicates proliferating and quiescent leukemia cells.EGFR Mutations Compromise Hypoxia-Associated Radiation Resistance through Impaired Replication Fork-Associated DNA Damage Repair.
P2860
Q26768267-1EF239D5-096B-453E-8AC1-F61BF6EDD396Q28540769-8805E70C-AF95-490D-9A3C-1EFD4B6EF269Q34453444-B77E5C24-7897-480B-A724-727DE71F525DQ36073749-D7F0C54D-0B94-4F18-9940-6C298F13D096Q39846614-CE23D6BF-BFB8-401B-A614-EECD6023C748Q40456709-53E147FF-A8E6-4C03-95B7-927096997051Q41964099-27DFE248-7576-46DA-9373-5A39B8393FEFQ42513590-093E0D88-CE1A-4007-8B2D-7DCE6541804C
P2860
EGFR-activating mutations correlate with a Fanconi anemia-like cellular phenotype that includes PARP inhibitor sensitivity.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
EGFR-activating mutations corr ...... es PARP inhibitor sensitivity.
@en
EGFR-activating mutations corr ...... es PARP inhibitor sensitivity.
@nl
type
label
EGFR-activating mutations corr ...... es PARP inhibitor sensitivity.
@en
EGFR-activating mutations corr ...... es PARP inhibitor sensitivity.
@nl
prefLabel
EGFR-activating mutations corr ...... es PARP inhibitor sensitivity.
@en
EGFR-activating mutations corr ...... es PARP inhibitor sensitivity.
@nl
P2093
P2860
P1433
P1476
EGFR-activating mutations corr ...... es PARP inhibitor sensitivity.
@en
P2093
Cyril H Benes
Heike N Pfäffle
Henning Willers
Jeffrey Settleman
Kerstin Borgmann
Lecia V Sequist
Liliana Gheorghiu
Natalie Ferraiolo
P2860
P304
P356
10.1158/0008-5472.CAN-13-0044
P407
P577
2013-08-21T00:00:00Z